PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
7945736-5	1994	The putative 5-HT1B agonist (m-trifluoromethyl-phenylpiperazine (TFMPP), but not [1-(3-chlorophenyl)piperazine] (m-CPP) or the 5-HT1B antagonists pindolol or quipazine, reduced the Bmax of cortical 5-HT1B sites (-16%).	Quipazine	158-167	5-hydroxytryptamine receptor 1B	Rattus norvegicus	13-19	
8152532-3	1993	Quipazine, an agonist at 5-HT1B/1C/2 receptors, significantly increased avoidance responding in a dose-dependent manner (1.25-10 mg/kg, s.c.).	Quipazine	0-9	5-hydroxytryptamine receptor 1B	Rattus norvegicus	25-31	
22158750-4	1987	The preferential 5-HT(1B) agonists RU-24969 and quipazine induced anorexia in unstressed rats and tended to supplement the anorectic effects of stress.	Quipazine	48-57	5-hydroxytryptamine receptor 1B	Rattus norvegicus	17-24	
2943219-8	1986	In contrast, putative 5-HT1B agonists (i.e. RU-24969 and quipazine) decrease feeding and cause anorexia.	Quipazine	57-66	5-hydroxytryptamine receptor 1B	Rattus norvegicus	22-28